We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Clearwater Paper
CLW
$341M
| $4.42K | ﹤0.01% |
141
-1,355
| -91% | -$43.7K |
|
1902
J. Jill
JILL
$351M
| $4.37K | ﹤0.01% |
204
-270
| -57% | -$6.2K |
|
1903
Hydrofarm Holdings
HYFM
$4.53M
| $4.28K | ﹤0.01% |
547
-8
| -1% | -$96 |
|
|
NUVL
1904
DELISTED
Nuvalent
NUVL
| $4.26K | ﹤0.01% |
101
-292
| -74% | -$11K |
|
1905
AB InBev
BUD
$156B
| $4.25K | ﹤0.01% |
75
-28
| -27% | -$1.69K |
|
1906
IMAX
IMAX
$2.89B
| $4.25K | ﹤0.01% |
+250
| New | +$4.74K |
|
1907
Bolt Biotherapeutics
BOLT
$7.76M
| $4.19K | ﹤0.01% |
164
-23
| -12% | -$730 |
|
1908
OneSpan
OSPN
$657M
| $4.13K | ﹤0.01% |
278
+86
| +45% | +$1.34K |
|
|
VWE
1909
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $4.12K | ﹤0.01% |
4,813
+1,155
| +32% | +$1.34K |
|
|
KRON
1910
DELISTED
Kronos Bio
KRON
| $4.12K | ﹤0.01% |
2,393
-166,134
| -99% | -$264K |
|
1911
Weis Markets
WMK
$1.78B
| $4.11K | ﹤0.01% |
64
-17
| -21% | -$1.24K |
|
1912
Bit Digital
BTBT
$527M
| $4.07K | ﹤0.01% |
+1,002
| New | +$2.59K |
|
|
TUP
1913
DELISTED
Tupperware Brands Corporation
TUP
| $4K | ﹤0.01% |
4,998
-361,011
| -99% | -$391K |
|
1914
Vroom Inc
VRM
$53.1M
| $3.97K | ﹤0.01% |
34
-38
| -53% | -$2.9K |
|
1915
Asure Software
ASUR
$245M
| $3.93K | ﹤0.01% |
323
| – | – |
|
1916
Pathward Financial
CASH
$1.65B
| $3.89K | ﹤0.01% |
84
| – | – |
|
1917
BP
BP
$121B
| $3.88K | ﹤0.01% |
+110
| New | +$4.07K |
|
1918
Honda
HMC
$41.8B
| $3.88K | ﹤0.01% |
128
-39,700
| -100% | -$1.12M |
|
1919
Trinity Industries
TRN
$2.24B
| $3.86K | ﹤0.01% |
150
-9
| -6% | -$206 |
|
1920
Spero Therapeutics
SPRO
$65.8M
| $3.84K | ﹤0.01% |
2,647
-2,206
| -45% | -$3.78K |
|
1921
Orthofix Medical
OFIX
$370M
| $3.77K | ﹤0.01% |
209
-72,455
| -100% | -$1.35M |
|
1922
Orrstown Financial Services
ORRF
$838M
| $3.73K | ﹤0.01% |
195
-103
| -35% | -$1.92K |
|
1923
Tilly's
TLYS
$147M
| $3.71K | ﹤0.01% |
529
-1,073
| -67% | -$7.87K |
|
|
CALB
1924
DELISTED
California BanCorp Common Stock
CALB
| $3.71K | ﹤0.01% |
247
+16
| +7% | +$249 |
|
1925
Aquestive Therapeutics
AQST
$604M
| $3.7K | ﹤0.01% |
+2,245
| New | +$4.06K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.